NOCTRIM FORTE Gummies
Food supplement declared in France, declaration No 2019-8-18
NOCTRIM FORTE Gummies is a food supplement declared in France. Status: retrait du marché annoncé pour le 31 December 2026. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- BIOCYTE
- Status
- Retrait du marché annoncé pour le 31 December 2026
- Form
- Gomme à mâcher
- Daily dose
- 1 gomme à mâcher
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous traitement médicamenteux
- Objectives stated by the manufacturer (these are not authorised claims)
- Sommeil
Declaration 165038, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 31 December 2026, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Mélatonine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Chlorhydrate de pyridoxine | Vitamine B6 | 12 mg | 2 mg |
Additives
E420, E330, E903
Other ingredients
sucre, sirop de glucose, Eau potable, gélatine, dextrose, Huile de coco, huile de colza, Cire d'abeille, maltodextrine, Concentré de spiruline et carthame
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.